Sign In
Buy IINN
$0.380
+0 (+0%)
At Close: Jul 31, 2026
RA'ANANA, Israel , Aug. 13, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) ("Inspira," "Inspira Technologies," or the "Company"), a trailblazer in life-supp
Inspira™ Technologies Introduces the INSPIRA Cardi-ART, Aiming to Provide Oxygen to the Brain During Cardiac Arrest
07:30am, Tuesday, 30'th Jul 2024
Inspira's innovation targets life-saving intervention for patients with cardiac arrest, of which there are approximately 550,000 annual cardiac arrest events in the U.S., including 350,000 outside hos
Inspira™ Receives Israeli Regulatory Approval for the INSPIRA™ ART100 System
08:30am, Thursday, 11'th Jul 2024
Approval follows the FDA clearance announced on May 28, 2024 RA'ANANA, Israel , July 11, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or
Inspira (IINN) Unveils Business Targets for 2024-25
12:16pm, Friday, 21'st Jun 2024
Inspira (IINN) discloses business goals for 2024-25 with the rapid promotion of INSPIRA ART100 and the development of INSPIRA ART (Gen 2).
Inspira™ Announces Business Plan Targets
09:25am, Thursday, 20'th Jun 2024
Company to aggressively promote INSPIRA™ ART100 in the U.S. and additional markets following FDA clearance, as well as accelerate plans for ground-breaking INSPIRA™ ART (Gen2) RA'ANANA, Israel ,
Inspira™ Introduces Advanced Life Support Solutions to Key International Leaders at the Annual iECOs Conference in Israel
08:30am, Monday, 17'th Jun 2024
RA'ANANA, Israel , June 17, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology co
Inspira™ Receives First Ever Purchase Order for INSPIRA™ ART100 Systems in the U.S.
08:30am, Thursday, 13'th Jun 2024
First units expected to be shipped in Q4 2024. The Purchase Order follows the recent FDA Clearance of the INSPIRA™ ART100.
Inspira™ to Exhibit the FDA Cleared INSPIRA™ ART100 System at a World-Renowned Event in the Sector
08:30am, Wednesday, 05'th Jun 2024
The event is an opportunity to present and demonstrate new products and technologies to potential customers and strategic partners RA'ANANA, Israel , June 5, 2024 /PRNewswire/ -- Inspira™ Technologi
Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments
08:30am, Thursday, 30'th May 2024
RA'ANANA, Israel , May 30, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira") a breakthrough medical technology company, announced today th
Inspira Technologies' (IINN) ART100 Gets FDA 510(k) Grant
01:16pm, Wednesday, 29'th May 2024
Inspira Technologies' (IINN) ART100 recent approval highlights the company's innovative advancements in medical technology.
INSPIRA™ ART100 Receives FDA 510(k) Clearance
09:25am, Tuesday, 28'th May 2024
RA'ANANA, Israel , May 28, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company", "Inspira", or "Inspira Technologies"), a breakthrough medical tec
Inspira™ Announces Start of Production of the INSPIRA™ ART100
09:18am, Thursday, 02'nd May 2024
RA'ANANA, Israel , May 2, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, announced the st
Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100
08:00am, Thursday, 25'th Apr 2024
RA'ANANA, Israel , April 25, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, annou
Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures
08:42am, Tuesday, 16'th Apr 2024
RA'ANANA, Israel , April 16, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, is pr
Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections
08:24am, Wednesday, 10'th Apr 2024
RA'ANANA, Israel , April 10, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, togeth
